[ Price : $8.95]
FDA announces a 3/30 workshop entitled Immune Globulin (IG) Hypersensitivity Reactions: Root Causes and Mitigation that is intende...[ Price : $8.95]
Researchers call on drug companies to ensure that labels for drugs with accelerated approval indications contain approval pathway ...[ Price : $8.95]
FDA says it is working with additional manufacturers of hemodialysis and peritoneal dialysis systems to determine the potential ri...[ Price : $8.95]
FDA grants Neuromod Devices a de novo request to market Lenire, the first bimodal neuromodulation device for treating tinnitus.[ Price : $8.95]
Aclaris Therapeutics says a Phase 2 clinical study investigating the efficacy and safety of zunsemetinib in treating hidradenitis ...[ Price : $8.95]
The Association for Accessible Medicines urges FDA to continue to revise a draft guidance on pre-submission facility correspondenc...[ Price : $8.95]
FDA accepts for review a Regeneron Pharmaceuticals supplemental BLA for Dupixent (dupilumab) for treating adults and adolescents a...[ Price : $8.95]
The National Cancer Institute raises concerns about an FDA guidance that requires studies of oncologic investigational agents to e...